Credit Suisse analyst Erin Wright maintained a Hold rating on Henry Schein (NASDAQ: HSIC) today and set a price target of $76. The company’s shares opened today at $71.58.
According to TipRanks.com, Wright is a 4-star analyst with an average return of 9.2% and a 66.9% success rate. Wright covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, PRA Health Sciences, and Charles River Labs.
Currently, the analyst consensus on Henry Schein is Moderate Buy and the average price target is $79.25, representing a 10.7% upside.
In a report issued on April 24, Goldman Sachs also downgraded the stock to Hold with a $72 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $93.50 and a one-year low of $62.56. Currently, Henry Schein has an average volume of 2.06M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments.
